Toggle Main Menu Toggle Search

ePrints

Browsing publications by Professor Julie Irving

Newcastle AuthorsTitleYearFull text
Liz Matheson
Huw Thomas
Marian Case
Dr Helen Blair
Rosanna Jackson
et al.
Glucocorticoids and selumetinib are highly synergistic in RAS pathway mutated childhood acute lymphoblastic leukemia through upregulation of BIM2019
Dr Craig Parker
Dr Lina Hamadeh
Professor Julie Irving
Professor Anthony Moorman
Late relapsing B-cell precursor acute lymphoblastic leukaemia with low minimal residual disease have survival of over 85% - results of the ALLR3 trial2019
Dr Lina Hamadeh
Professor Julie Irving
Professor Anthony Moorman
Outcomes of patients with childhood B-cell precursor acute lymphoblastic leukaemia with late bone marrow relapses: long-term follow-up of the ALLR3 open-label randomised trial2019
Dr Paul Sinclair
Dr Sarra Ryan
Dr Matthew Bashton
Shaun Hollern
Rebecca Hanna
et al.
SH2B3 inactivation through CN-LOH-12q is uniquely associated with B-cell precursor ALL with iAMP21 or other chromosome 21 gain2019
Professor Julie Irving
Professor Anthony Moorman
International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemia2018
Jean Norden
Dr Kim Pearce
Professor Julie Irving
Professor Matthew Collin
Professor Anne Dickinson
et al.
The influence of glucocorticoid receptor single nucleotide polymorphisms on outcome after haematopoietic stem cell transplantation2018
Professor Anthony Moorman
Professor Julie Irving
Professor James Allan
Professor Christine Harrison
A genome-wide association study identifies risk loci for childhood acute lymphoblastic leukemia at 10q26.13 and 12q23.12017
Dr Britta Vormoor
Professor Gareth Veal
Melanie Griffin
Professor Julie Irving
Lynne Minto
et al.
A phase I/II trial of AT9283, a selective inhibitor of aurora kinase in children with relapsed or refractory acute leukemia: challenges to run early phase clinical trials for children with leukemia2017
Zach Dixon
Dr Lindsay Nicholson
Elizabeth Matheson
Dr Paul Sinclair
Professor Christine Harrison
et al.
CREBBP knockdown enhances RAS/RAF/MEK/ERK signaling in Ras pathway mutated acute lymphoblastic leukemia but does not modulate chemotherapeutic response2017
Professor Julie Irving
Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemia2017
12345678910111213